New drugs on the horizon may improve the quality and safety of anesthesia.
Joel M
JM
Weaver
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000762:Anesthesia Recovery Period; D002316:Cardiotonic Agents / Q000494:pharmacology*; D005217:Fat Emulsions, Intravenous / Q000494:pharmacology*; D006801:Humans; D009465:Neuromuscular Agents / Q000494:pharmacology*; D010646:Phentolamine / Q000494:pharmacology*; D000077122:Sugammadex; D047408:gamma-Cyclodextrins / Q000494:pharmacology*
D000317:Adrenergic alpha-Antagonists; D002316:Cardiotonic Agents; D005217:Fat Emulsions, Intravenous; D009465:Neuromuscular Agents; D047408:gamma-Cyclodextrins; D000077122:Sugammadex; D010646:Phentolamine